Bond.az White LogoBond.az Black Logo

Newcleo to Go Public via SPAC Merger at $2.4B Valuation

Newcleo merges with SPAC NewHold at $2.4B valuation, lists on Nasdaq as NWCL. PIPE of $220M included. Transaction expected to close in 2026.

Aria Wright
ByAria Wright- Senior Editor
|
0

PARIS and NEW YORK - Newcleo Ltd., a nuclear energy company developing lead-cooled fast reactors and mixed oxide fuel, announced today it has entered into a definitive agreement to merge with NewHold Investment Corp III (NASDAQ:NHIC).

The transaction values Newcleo at a pre-money equity value of approximately $2.4 billion and is expected to provide up to $429 million in gross proceeds from a combination of $220 million in PIPE and up to $209 million of cash held in NewHold's trust account.

NewHold's stock surged 12.5% over the past week ahead of the announcement. The combined company is expected to list on the Nasdaq under the ticker NWCL, with the transaction closing in the second half of 2026.

Founded in 2021, Newcleo operates in seven countries with over 900 employees and generated approximately $80 million in revenue in 2024. The company has raised about $780 million in private funds since its founding.

Newcleo is developing 200MWe commercial reactor designs and MOX fuel produced from reprocessed nuclear waste. The company has a joint venture with JAVYS in Slovakia to deploy up to four reactors at the Bohunice site.

In October 2025, Newcleo partnered with Oklo Inc. to build advanced fuel manufacturing infrastructure in the U.S. The transaction is subject to shareholder and regulatory approvals.

More News
2026-06-01 12:34
|
401

Amber International shareholder to distribute stake pro rata

Amber International's principal shareholder distributes all Class A shares pro rata to existing shareholders; market impact and financial highlights.

0
2026-06-01 12:33
|
213

Palladyne AI Adds Two Retired Generals to Board

Palladyne AI appoints two retired generals to its defense advisory board. Stock up 98% YTD.

0
2026-06-01 12:32
|
381

Cellectar Plans Phase 3 Trial for WM After BTKi

Cellectar Biosciences reports promising Phase 2 results for iopofosine I 131 in Waldenström macroglobulinemia after BTKi therapy, plans Phase 3 trial.

0
2026-06-01 11:33
|
363

essensys Shareholders Approve Re-Registration as Private Company

essensys shareholders approve re-registration as a private company after AIM delisting. All voting shareholders backed the resolution.

0
2026-06-01 08:31
|
890

Causeway Capital Boosts Melrose Stake to 5.12%

Causeway Capital increased its stake in Melrose Industries to 5.12%. The investment firm now holds over 63 million voting rights.

0
2026-06-01 08:03
|
968

Ignitis grupė starts search for new CEO

Ignitis grupė launches CEO search in Lithuania. Learn about requirements and application deadline for the new CEO position.

0
2026-06-01 07:33
|
417

Aquila Renewables: Adviser Withholds Fee Data

Aquila European Renewables says its investment adviser Aquila Capital has not provided complete fee information. The Board is considering legal action.

0
2026-06-01 07:31
|
226

USA Rare Earth Plans €175M France Investment

USA Rare Earth reveals €175 million investment plan in France for metal, alloy and magnet manufacturing, aiming to create over 300 jobs by 2030.

0
2026-06-01 07:30
|
762

Lucid Group Names Silvio Napoli CEO

Lucid Group appoints Silvio Napoli as CEO effective immediately. Stock up 12% in past week but down 38% YTD. Company faces financial challenges.

0
2026-06-01 07:04
|
680

Mkango Reports Q1 2026 Financial Results

Mkango Resources reports Q1 2026 financial results. Details on rare earth projects, recycling operations, and SPAC merger.

0
2026-06-01 07:02
|
274

Greatland secures $500m debt facility, OKs Havieron

Greatland Resources secures $500 million corporate debt facility and board approval for Havieron gold-copper project final investment decision.

0
2026-06-01 07:00
|
543

Calnex director buys shares at 69.9p

Calnex Solutions non-executive director Graeme Bissett buys 28,610 shares at 69.9p each on the London Stock Exchange.

0
...
Newcleo to Go Public via SPAC Merger at $2.4B Valuation | Bond.az